Spots Global Cancer Trial Database for Safety and Feasibility Study of Enhanced Recovery in Pancreaticoduodenectomy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Safety and Feasibility Study of Enhanced Recovery in Pancreaticoduodenectomy

Official Title: Safety and Feasibility Study of an Enhanced Recovery After Surgery Protocol in Patients Undergoing Elective Pancreaticoduodenectomy.

Study ID: NCT01759706

Conditions

Pancreatic Neoplasms

Interventions

Enhanced recovery after surgery protocol

Standard perioperative care

PONV prophylaxis with Ondansetron + Dexamethasone

Postoperative mobilization program

Epidural analgesia with naropin + sufentanil

Pre-anesthetic medication with diazepam

Preadmission counselling

Preoperative bowel preparation with sodium phosphate

Study Description

Brief Summary: The purpose of this study is to assess the adherence to an enhanced recovery after surgery (ERAS) pathway and the impact of the ERAS protocol on postoperative short-term outcome in patients undergoing pancreaticoduodenectomy (PD).

Detailed Description: A specific enhanced recovery after surgery (ERAS) protocol has been applied since October 2010 in consecutive patients undergoing pancreaticoduodenectomy (PD) in a high volume Institution. Patient compliance for each item has been assessed. Each ERAS patient was matched with a patient who received standard perioperative care. Match criteria were age, gender, malignant / benign disease, and PD prognostic score.